Clinical Trials Act 2011Section 28
28. Notification of serious adverse event or reaction
(1) An investigator shall, within 24 hours of becoming aware of a
serious adverse event or serious adverse reaction, inform the sponsor of the
event or reaction.
(2) Where the sponsor receives information under subsection (1), it
shall, within 24 hours, notify the Council and Pharmacovigilance Committee
in writing of the serious adverse event or serious adverse reaction.
(3) A sponsor shall provide such follow-up information relating to
the serious adverse event or serious adverse reaction as the Council or
Pharmacovigilance Committee may require.
PART IX – REGISTER OF CLINICAL TRIALS